Learn how utilizing health coaching skills in your practice is crucial to your success, leaving a lasting impact on your clients, and shifting the paradigm of womens healthcare
Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges
Our findings suggest that semaglutide does not decrease withdrawal-like symptoms in escalated animals: those trained under long-access conditions and that have a dependence-like phenotype more similar to that of humans with OUD
Whether you are using a compounded vial or an FDA-approved pen, this is the reference you will keep coming back to
Given the popularity of GLP-1 medications, its not surprising that health food and supplement brands are trying to capitalize on the trend, says Michael Snyder, MD, an in-house obesity specialist at FuturHealth and medical director of the Bariatric Surgery Center at Rose Medical Center